Mechanisms underpinning the polypharmacy effects of medications in psychiatry
Version 4 2025-09-09, 06:10
Version 3 2024-06-18, 07:14
Version 2 2024-06-05, 07:10
Version 1 2018-06-01, 00:00
journal contribution
posted on 2025-09-09, 06:10 authored by Chiara BortolasciChiara Bortolasci, Briana RandallBriana Randall, E Callaly, S Martin, B Panizzutti, S Kidnapillai, Timothy ConnorTimothy Connor, K Hasebe, Mohammadreza MohebbiMohammadreza Mohebbi, Olivia DeanOlivia Dean, Sean McgeeSean Mcgee, Seetal DoddSeetal Dodd, Laura GrayLaura Gray, Michael BerkMichael Berk, Ken WalderKen WalderMechanisms underpinning the polypharmacy effects of medications in psychiatry
History
Related Materials
- 1.
Location
EnglandLink to full text
Language
EnglishPublication classification
C1 Refereed article in a scholarly journalCopyright notice
2018, The AuthorsJournal
International Journal of NeuropsychopharmacologyVolume
21Pagination
582-591ISSN
1461-1457eISSN
1469-5111Issue
6Publisher
OXFORD UNIV PRESSUsage metrics
Categories
No categories selectedKeywords
Science & TechnologyLife Sciences & BiomedicineClinical NeurologyNeurosciencesPharmacology & PharmacyPsychiatryNeurosciences & Neurologypsychiatrybipolar disorderpolypharmacyinflammationmitochondrial functionBIPOLAR DISORDEROXIDATIVE STRESSMITOCHONDRIAL DYSFUNCTIONGENE-EXPRESSIONCYTOKINE LEVELSLITHIUMINFLAMMATIONMETAANALYSISDEPRESSIONMICROGLIA110999 Neurosciences not elsewhere classified920410 Mental HealthFaculty of HealthSchool of MedicineInstitute for Innovation in Mental and Physical Health and Clinical Translation3209 Neurosciences3202 Clinical sciences3214 Pharmacology and pharmaceutical sciences420313 Mental health services200409 Mental health
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC